Advances in Photodynamic Therapy for Cancer

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".

Deadline for manuscript submissions: 30 July 2024 | Viewed by 133

Special Issue Editor

E-Mail Website1 Website2
Guest Editor
Laboratório de Dinâmica de Compartimento Celulares, Research and Development Institute (IP & D), University of Vale do Paraíba (UNIVAP), Avenida Shishima Hifumi 2911, São José dos Campos 12244-000, SP, Brazil
Interests: cell biology; cancer; cell culture; spheroids

Special Issue Information

Dear Colleagues,

According to the World Health Organization (WHO), cancer is the second leading cause of death in the world, responsible for 9.5 million deaths in 2020. This number is estimated to increase to 13.2 million deaths in 2030. The incidence of cancer varies depending on the region of the world. Low-income countries have lower incidence rates, but they also have higher mortality rates.

Photodynamic therapy (PDT) is emerging as a revolutionary weapon in the fight against cancer. This Special Issue delves into the cutting-edge advancements in PDT, showcasing its potential to transform cancer treatment. PDT has the potential to become a more effective and less toxic treatment for cancer. As research continues, PDT may become a more widely available treatment option for cancer patients.

PDT has the potential to significantly increase cure rates and improve the quality of life of cancer patients.

In this Special Issue, we aim to draw together research from experts in the field that highlight therapeutic agents and strategies in PDT and identify future directions that will lead to discoveries and therapies for cancer.

Prof. Dr. Cristina Pacheco-Soares
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • photodynamic therapy
  • cancer treatment
  • photosensitizers
  • targeted therapy
  • combination therapies
  • mechanisms of action
  • molecular biology

Published Papers

This special issue is now open for submission.
Back to TopTop